Template:Infectious Disease Project Antimicrobial Agents: Difference between revisions

Infectious Disease Project
Mission Statement
Antimicrobial Agents
	▸ Alphabetical List A ● B ● C ● D ● E ● F ● G ● H ● I ● K ● L ● M ● N ● O ● P ● Q ● R ● S ● T ● V ● Z
	▸ Categorical List Antibacterial Agents ● Antimycobacterial Agents ● Antifungal Agents ● Antiparasitic Agents ● Antiviral Agents ● Antiretroviral Agents Natural Penicillins ● Antistaphylococcal Penicillins ● Aminopenicillins ● Antipseudomonal Penicillins ● Carbapenems ● Monobactam ● Cephalosporins – 1st Generation ● Cephalosporins – 2nd Generation ● Cephalosporins – 3rd and 4th Generation ● Aminoglycosides ● Fluoroquinolones ● Glycopeptides ● Lincosamides ● Macrolides ● Ketolide ● Nitroimidazoles ● Oxazolidinones ● Polymyxins and Colistin ● Rifamycin ● Streptogramins ● Tetracyclines ● Glycylcycline ● Antifolates ● Fusidanes ● Topical Antibacterials ● Urinary Tract Agents
	▸ Generic & Brand Names Generic Name ➡︎ Brand Name ● Brand Name ➡︎ Generic Name
	▸ Pregnancy Categories Antibacterial ● Antimycobacterial ● Antifungal ● Antiparasitic ● Antiviral ● FDA Pregnancy Categories
	▸ TdP & QTc Prolongation TdP Risk Categories ● Stratification Schedules
	▸ CYP Isoenzymes CYP Substrates ● CYP Inhibitors ● CYP Inducers
	▸ Antimicrobial Spectrum
	▸ Dosage Adjustment Renal Dose ● Hepatic Dose
Organ-Based Infections
Pathogen-Based Infections
Editing FAQ
Gallery

VisualWikitext

@@ Line 98: / Line 98: @@
 </div>
 |-
-| style="padding: 3px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 12px;" | <div class="mw-customtoggle-x7" style="cursor: pointer;>{{Fontcolor|#FFFFFF|&nbsp;&nbsp;▸&nbsp;&nbsp;Antimicrobial Spectrum}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x7" style="font-size: 10px;">
+| style="padding: 3px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 12px;" | [[Infectious Disease Project Antimicrobial Agents#Antimicrobial Spectrum, Dosing Information, and Adverse Reaction Return to Top|{{Fontcolor|#FFFFFF|&nbsp;&nbsp;▸&nbsp;&nbsp;Antimicrobial Spectrum}}]]
-----
-[[Infectious Disease Project Antimicrobial Agents#Antimicrobial Spectrum, Dosing Information, and Adverse Reaction Return to Top|{{Fontcolor|#FFFFFF|'''Antimicrobial Spectrum'''}}]] &nbsp;●&nbsp;
-[[Infectious Disease Project Antimicrobial Agents#Antimicrobial Spectrum, Dosing Information, and Adverse Reaction Return to Top|{{Fontcolor|#FFFFFF|'''Regular Dosage'''}}]] &nbsp;●&nbsp;
-[[Infectious Disease Project Antimicrobial Agents#Antimicrobial Spectrum, Dosing Information, and Adverse Reaction Return to Top|{{Fontcolor|#FFFFFF|'''Adverse Reaction'''}}]]
-</div>
 |-
 | style="padding: 3px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 12px;" | <div class="mw-customtoggle-x8" style="cursor: pointer;>{{Fontcolor|#FFFFFF|&nbsp;&nbsp;▸&nbsp;&nbsp;Dosage Adjustment}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x8" style="font-size: 10px;">
@@ Line 114: / Line 109: @@
 |-
 ! style="padding: 3px 3px; background: #3F3F3F; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 14px;" | [[Infectious Disease Project Pathogen-Based Infections|{{Fontcolor|#21B6A8|Pathogen-Based Infections}}]]
+|-
+! style="padding: 3px 3px; background: #3F3F3F; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 14px;" | [[Infectious Disease Project Editing FAQ|{{Fontcolor|#21B6A8|Editing FAQ}}]]
 |-
 ! style="padding: 3px 3px; background: #3F3F3F; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 14px;" | [[Infectious Disease Project Gallery|{{Fontcolor|#21B6A8|Gallery}}]]
 |}

Template:Infectious Disease Project Antimicrobial Agents: Difference between revisions

Latest revision as of 17:29, 18 August 2015

Navigation menu